MedTrace Logo

MRI Screening in Men at High Risk of Developing Prostate Cancer

NCT05608694 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2026-03-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.

Conditions

  • Prostate Cancer Screening

Interventions

OTHER

Prostate MRI

Group placement is determined by GRS score, Family history, and germline testing

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Scott Eggener, MD · University of Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-02
Primary Completion
2037-03-01
Completion
2039-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05608694 on ClinicalTrials.gov